Molecular Imaging of Coronary Atherosclerosis and Myocardial Infarction: Considerations for the Bench and Perspectives for the Clinic

Motivated by the promise to transform preclinical research and clinical care, cardiovascular molecular imaging has made advances toward targeting coronary atherosclerosis and heart failure. Here, we discuss recent progress in the field, highlight how molecular imaging may facilitate preventive patient care, and review specific challenges associated with coronary and heart failure imaging. Practical considerations stress the potential of fluorescence imaging for basic research and discuss hybrid protocols such as FMT-CT and PET-MRI.

[1]  E. Braunwald.  Epilogue: what do clinicians expect from imagers? , 2006, Journal of the American College of Cardiology.

[2]  R. Ferrari,et al.  Factor XIIIA-V34L and Factor XIIIB-H95R Gene Variants: Effects on Survival in Myocardial Infarction Patients , 2007, Molecular medicine.

[3]  R. Gropler,et al.  Radionuclide Imaging of Myocardial Metabolism , 2010, Circulation. Cardiovascular imaging.

[4]  G. Dai,et al.  Molecular MRI Detects Low Levels of Cardiomyocyte Apoptosis in a Transgenic Model of Chronic Heart Failure , 2009, Circulation. Cardiovascular imaging.

[5]  P. Libby,et al.  The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions , 2007, The Journal of experimental medicine.

[6]  M. E. Kooi,et al.  Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging , 2003, Circulation.

[7]  R. Kim,et al.  Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications. , 2009, Journal of the American College of Cardiology.

[8]  Bijoy Kundu,et al.  Images in cardiovascular medicine. Serial multimodality assessment of myocardial infarction in mice using magnetic resonance imaging and micro-positron emission tomography provides complementary information on the progression of scar formation. , 2007, Circulation.

[9]  Ahmed Tawakol,et al.  Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography , 2005, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[10]  Ciprian Catana,et al.  Simultaneous PET-MRI: a new approach for functional and morphological imaging , 2008, Nature Medicine.

[11]  V. Fuster,et al.  Targeted Molecular Probes for Imaging Atherosclerotic Lesions With Magnetic Resonance Using Antibodies That Recognize Oxidation-Specific Epitopes , 2008, Circulation.

[12]  René M. Botnar,et al.  Molecular Coronary MR Imaging of Human Thrombi using EP-2104R, a Fibrin-Targeted Contrast Agent: Experimental Study in a Swine Model , 2007, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[13]  Michael Z. Lin,et al.  Mammalian Expression of Infrared Fluorescent Proteins Engineered from a Bacterial Phytochrome , 2009, Science.

[14]  Samuel A. Wickline,et al.  Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With &agr;v&bgr;3-Integrin–Targeted Nanoparticles , 2003 .

[15]  D. Dione,et al.  Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. , 2004, The Journal of clinical investigation.

[16]  Axel Thran,et al.  Atherosclerotic Plaque Composition : Analysis with Multicolor CT and Targeted Gold Nanoparticles 1 , 2010 .

[17]  P. Libby,et al.  Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. , 2010, Journal of the American College of Cardiology.

[18]  M. Schwaiger,et al.  The Future of Cardiovascular Imaging in the Diagnosis and Management of Heart Failure, Part 2: Clinical Applications , 2008, Circulation. Cardiovascular imaging.

[19]  Ralph Weissleder,et al.  Dual Channel Optical Tomographic Imaging of Leukocyte Recruitment and Protease Activity in the Healing Myocardial Infarct , 2007, Circulation research.

[20]  Vasilis Ntziachristos,et al.  Hybrid System for Simultaneous Fluorescence and X-Ray Computed Tomography , 2010, IEEE Transactions on Medical Imaging.

[21]  B. Pitt,et al.  Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction. , 2008, Journal of the American College of Cardiology.

[22]  Martin J Graves,et al.  The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. , 2009, Journal of the American College of Cardiology.

[23]  R. Weissleder,et al.  Angiotensin-Converting Enzyme Inhibition Prevents the Release of Monocytes From Their Splenic Reservoir in Mice With Myocardial Infarction , 2010, Circulation research.

[24]  A. Sinusas,et al.  Alphavbeta3-targeted detection of arteriopathy in transplanted human coronary arteries: an autoradiographic study. , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  D. Dione,et al.  Noninvasive Targeted Imaging of Matrix Metalloproteinase Activation in a Murine Model of Postinfarction Remodeling , 2005, Circulation.

[26]  R. Weissleder,et al.  Imaging in the era of molecular oncology , 2008, Nature.

[27]  Otmar Schober,et al.  Scintigraphic Imaging of Matrix Metalloproteinase Activity in the Arterial Wall In Vivo , 2004, Circulation.

[28]  D. Mozaffarian,et al.  Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[29]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[30]  V. Fuster,et al.  Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? , 2010, Journal of the American College of Cardiology.

[31]  P. Libby,et al.  Activatable Magnetic Resonance Imaging Agent Reports Myeloperoxidase Activity in Healing Infarcts and Noninvasively Detects the Antiinflammatory Effects of Atorvastatin on Ischemia-Reperfusion Injury , 2008, Circulation.

[32]  Vasilis Ntziachristos,et al.  Real-Time Catheter Molecular Sensing of Inflammation in Proteolytically Active Atherosclerosis , 2008, Circulation.

[33]  D. Kraitchman,et al.  Advances in Cardiovascular Imaging Multimodality Cardiovascular Molecular Imaging, Part II , 2008 .

[34]  Zahi A Fayad,et al.  Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography , 2007, Nature Medicine.

[35]  R. Weissleder,et al.  Myeloperoxidase-rich Ly-6C+ myeloid cells infiltrate allografts and contribute to an imaging signature of organ rejection in mice. , 2010, The Journal of clinical investigation.

[36]  Z. Fayad,et al.  Magnetic Resonance Molecular Imaging of Thrombosis in an Arachidonic Acid Mouse Model Using an Activated Platelet Targeted Probe , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[37]  F. Epstein,et al.  Multimodality cardiovascular molecular imaging, part I. , 2008, Circulation. Cardiovascular imaging.

[38]  R. Weissleder,et al.  Hybrid PET-optical imaging using targeted probes , 2010, Proceedings of the National Academy of Sciences.

[39]  V. Ntziachristos.  Going deeper than microscopy: the optical imaging frontier in biology , 2010, Nature Methods.

[40]  M. Scherrer-Crosbie,et al.  Ventricular remodeling and function: insights using murine echocardiography. , 2010, Journal of molecular and cellular cardiology.

[41]  Stefan Frantz,et al.  Healing after myocardial infarction. , 2005, Cardiovascular research.

[42]  M. Olschewski,et al.  Magnetic Resonance Imaging Contrast Agent Targeted Toward Activated Platelets Allows In Vivo Detection of Thrombosis and Monitoring of Thrombolysis , 2008, Circulation.

[43]  V. Fuster,et al.  Macrophage-specific lipid-based nanoparticles improve cardiac magnetic resonance detection and characterization of human atherosclerosis. , 2009, JACC. Cardiovascular imaging.

[44]  G. Dai,et al.  Abstract 593: Molecular MRI of Cardiomyocyte Apoptosis With Simultaneous Delayed Enhancement MRI Distinguishes Apoptotic and Necrotic Myocytes in vivo: Potential for Midmyocardial Salvage in Acute Ischemia , 2009 .

[45]  R. Weissleder,et al.  Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: implications for FXIII therapy and antithrombin use in myocardial infarction. , 2008, European heart journal.

[46]  R. Kim,et al.  Cardiovascular MRI: its current and future use in clinical practice , 2007, Expert review of cardiovascular therapy.

[47]  M. Schwaiger,et al.  Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart. , 1998, Circulation.

[48]  A. Arai,et al.  Advances in clinical applications of cardiovascular magnetic resonance imaging , 2008, Heart.

[49]  Vasilis Ntziachristos,et al.  In Vivo Imaging of Proteolytic Activity in Atherosclerosis , 2002, Circulation.

[50]  B. Tromberg,et al.  Noninvasive imaging of angiotensin receptors after myocardial infarction. , 2008, JACC. Cardiovascular imaging.

[51]  Shelton D Caruthers,et al.  Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. , 2003, Circulation.

[52]  Ralph Weissleder,et al.  Hybrid In Vivo FMT-CT Imaging of Protease Activity in Atherosclerosis With Customized Nanosensors , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[53]  René M. Botnar,et al.  Coronary Magnetic Resonance Angiography , 2003, Herz.

[54]  R. Virmani,et al.  Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. , 1997, The New England journal of medicine.

[55]  Francis G Spinale,et al.  Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. , 2007, Physiological reviews.

[56]  P. Libby,et al.  Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites , 2009, Science.

[57]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[58]  A. Sinusas,et al.  Molecular Imaging of Activated Matrix Metalloproteinases in Vascular Remodeling , 2008, Circulation.

[59]  T. Akasaka,et al.  Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. , 2009, Journal of the American College of Cardiology.

[60]  Seung‐Jung Park,et al.  Impact of plaque characteristics analyzed by intravascular ultrasound on long-term clinical outcomes. , 2009, American Journal of Cardiology.

[61]  Erling Falk,et al.  Plaque rupture in humans and mice. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[62]  Zahi A. Fayad,et al.  Imaging of atherosclerotic cardiovascular disease , 2008, Nature.

[63]  Ralph Weissleder,et al.  Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto‐optical nanoparticle , 2005, Magnetic resonance in medicine.

[64]  H. Crijns,et al.  Noninvasive Detection of Programmed Cell Loss with 99mTc-Labeled Annexin A5 in Heart Failure , 2007, Journal of Nuclear Medicine.

[65]  A. Sinusas,et al.  Detection of Injury-Induced Vascular Remodeling by Targeting Activated &agr;vβ3 Integrin In Vivo , 2004 .

[66]  D. Berman,et al.  Optimal medical therapy with or without PCI for stable coronary disease. , 2007, The New England journal of medicine.

[67]  Jiqiu Chen,et al.  Near-Infrared Fluorescent Imaging of Matrix Metalloproteinase Activity After Myocardial Infarction , 2005, Circulation.

[68]  M. Pittet,et al.  Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. , 2010, Circulation.

[69]  Vasilis Ntziachristos,et al.  Fluorescence Tomography and Magnetic Resonance Imaging of Myocardial Macrophage Infiltration in Infarcted Myocardium In Vivo , 2007, Circulation.

[70]  Bruce D Cheson,et al.  Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development , 2005, Clinical Cancer Research.

[71]  A. Sinusas,et al.  αvβ3‐Targeted detection of arteriopathy in transplanted human coronary arteries: an autoradiographic study , 2005 .

[72]  M. Lindsey,et al.  Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction. , 2012, Cardiovascular therapeutics.

[73]  S. Cherry,et al.  Simultaneous in vivo positron emission tomography and magnetic resonance imaging , 2008, Proceedings of the National Academy of Sciences of the United States of America.

[74]  Ralph Weissleder,et al.  Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates. , 2006, Radiology.

[75]  M. Entman,et al.  The inflammatory response in myocardial infarction. , 2002, Cardiovascular research.

[76]  Vasilis Ntziachristos,et al.  Born Normalization for Fluorescence Optical Projection Tomography for Whole Heart Imaging , 2009, Journal of visualized experiments : JoVE.

[77]  S. Nekolla,et al.  In vivo molecular imaging of angiogenesis, targeting alphavbeta3 integrin expression, in a patient after acute myocardial infarction. , 2008, European heart journal.

[78]  P. Choyke,et al.  Imaging of angiogenesis: from microscope to clinic , 2003, Nature Medicine.

[79]  W. Stuetzle,et al.  PET measures of pre- and post-synaptic cardiac beta adrenergic function. , 2003, Nuclear medicine and biology.

[80]  R. Weissleder,et al.  A DNA-binding Gd chelate for the detection of cell death by MRI. , 2009, Chemical communications.

[81]  J. Roelandt,et al.  Images in Cardiovascular Medicine , 2000 .

[82]  Rolf Schubert,et al.  In Vivo Monitoring of Inflammation After Cardiac and Cerebral Ischemia by Fluorine Magnetic Resonance Imaging , 2008, Circulation.

[83]  A. Walch,et al.  Evaluation of &agr;v&bgr;3 Integrin-Targeted Positron Emission Tomography Tracer 18F-Galacto-RGD for Imaging of Vascular Inflammation in Atherosclerotic Mice , 2009, Circulation. Cardiovascular imaging.

[84]  Biplab Das,et al.  Collagen-targeted MRI contrast agent for molecular imaging of fibrosis. , 2007, Angewandte Chemie.

[85]  Ralph Weissleder,et al.  Enzyme-Sensitive Magnetic Resonance Imaging Targeting Myeloperoxidase Identifies Active Inflammation in Experimental Rabbit Atherosclerotic Plaques , 2009, Circulation.

[86]  H. Sipilä,et al.  Cardiac Positron Emission Tomography/Computed Tomography Imaging Accurately Detects Anatomically and Functionally Significant Coronary Artery Disease , 2010, Circulation.

[87]  Evert-Jan Vonken,et al.  Improved SNR efficiency in gradient echo coronary MRA with high temporal resolution using parallel imaging , 2009, Magnetic resonance in medicine.

[88]  James E. Muller,et al.  Detection and Treatment of Vulnerable Plaques and Vulnerable Patients: Novel Approaches to Prevention of Coronary Events , 2006, Circulation.

[89]  S. Kaul,et al.  Noninvasive Imaging of Myocardial Reperfusion Injury Using Leukocyte-Targeted Contrast Echocardiography , 2002, Circulation.

[90]  R. Morin,et al.  Ionizing Radiation in Cardiac Imaging: A Science Advisory From the American Heart Association Committee on Cardiac Imaging of the Council on Clinical Cardiology and Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention , 2009, Circulation.

[91]  Renu Virmani,et al.  Pathology of the vulnerable plaque. , 2007, Journal of the American College of Cardiology.

[92]  Zahi A Fayad,et al.  Atherothrombosis and high-risk plaque: Part II: approaches by noninvasive computed tomographic/magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.

[93]  Greg M Thurber,et al.  18F labeled nanoparticles for in vivo PET-CT imaging. , 2009, Bioconjugate chemistry.

[94]  R. Weissleder,et al.  Factor XIII Deficiency Causes Cardiac Rupture, Impairs Wound Healing, and Aggravates Cardiac Remodeling in Mice With Myocardial Infarction , 2006, Circulation.

[95]  Paul W Armstrong,et al.  Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. , 2009, Journal of the American College of Cardiology.

[96]  S. Pocock,et al.  Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. , 2003, Journal of the American College of Cardiology.

[97]  Ahmed Tawakol,et al.  Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina. , 2010, JACC. Cardiovascular imaging.

[98]  E. Kleinhans,et al.  Results of interventional treatment of stress positive coronary artery disease. , 2010, The American journal of cardiology.

[99]  R. Weissleder,et al.  Oxazine conjugated nanoparticle detects in vivo hypochlorous acid and peroxynitrite generation. , 2009, Journal of the American Chemical Society.

[100]  Ralph Weissleder,et al.  Noninvasive Vascular Cell Adhesion Molecule-1 Imaging Identifies Inflammatory Activation of Cells in Atherosclerosis , 2006, Circulation.

[101]  Vasilis Ntziachristos,et al.  Near-infrared fluorescence catheter system for two-dimensional intravascular imaging in vivo. , 2010, Optics express.

[102]  Ahmed Tawakol,et al.  In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. , 2006, Journal of the American College of Cardiology.

[103]  Joseph Lau,et al.  The Vulnerable Atherosclerotic Plaque: Scope of the Literature , 2010, Annals of Internal Medicine.

[104]  P. Jakob,et al.  Assessment of Cardiovascular Apoptosis in the Isolated Rat Heart by Magnetic Resonance Molecular Imaging , 2006, Molecular imaging.

[105]  A. Sinusas,et al.  Detection of injury-induced vascular remodeling by targeting activated alphavbeta3 integrin in vivo. , 2004, Circulation.

[106]  Matthias Stuber,et al.  Controversies in cardiovascular medicine series Imaging of the unstable plaque : how far have we got ? , 2009 .

[107]  Brian J. Bennett,et al.  Progression and disruption of advanced atherosclerotic plaques in murine models. , 2008, Current drug targets.

[108]  J. Wykrzykowska,et al.  Imaging of Inflamed and Vulnerable Plaque in Coronary Arteries with 18F-FDG PET/CT in Patients with Suppression of Myocardial Uptake Using a Low-Carbohydrate, High-Fat Preparation , 2009, Journal of Nuclear Medicine.

[109]  S. Gambhir,et al.  Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.

[110]  Ralph Weissleder,et al.  18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis. , 2009, JACC. Cardiovascular imaging.

[111]  S. Normand,et al.  Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. , 2009, JAMA.

[112]  Zahi A Fayad,et al.  Nanotechnology in Medical Imaging: Probe Design and Applications , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[113]  Patrick A Helm,et al.  Postinfarction myocardial scarring in mice: molecular MR imaging with use of a collagen-targeting contrast agent. , 2008, Radiology.

[114]  J. Lindner,et al.  Molecular Imaging of Inflammation in Atherosclerosis With Targeted Ultrasound Detection of Vascular Cell Adhesion Molecule-1 , 2007, Circulation.

[115]  Z. Fayad,et al.  Fractionated feridex and positive contrast: In vivo MR imaging of atherosclerosis , 2008, Magnetic resonance in medicine.

[116]  Vasilis Ntziachristos,et al.  Shedding light onto live molecular targets , 2003, Nature Medicine.

[117]  Ralph Weissleder,et al.  Nanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis , 2008, Circulation.

[118]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[119]  P. Doevendans,et al.  Visualisation of cell death in vivo in patients with acute myocardial infarction , 2000, The Lancet.